7th National Conference on Laboratory Aspects of Tuberculosis

More than 140 participants attended the 7th National Conference on Laboratory Aspects of Tuberculosis which was held in Atlanta, GA, June 13-15, 2011. The two-day conference was co-located with the National TB Controller’s Association’s National TB Conference for the second time.  Speakers addressed implementation of new technologies in the TB laboratory, new CLSI recommendations for Mycobacteriology Drug Susceptibility Testing, and approaches for assuring quality in the TB Laboratory. The keynote address was given by Dr. William Burman, University of Colorado.

Slide Presentations

The conference schedule is listed below; presentations with links have been authorized to be posted on this website. Duplication is not authorized without the express written permission of the authors. The author and “7th National Conference on Laboratory Aspects of Tuberculosis” must be cited once permission is received.

Note: See below for instructions on downloading and viewing large files

Monday June 13

Opening Session
Moderator- Edward P. Desmond, PhD, D(ABMM), California Department of Public Health

Keynote Address – What is Drug Resistance? Musings of a Clinician
- William Burman, MD, University of Colorado

State of TB
- Michael F. Iademarco, MD, MPH, Centers for Disease Control and Prevention

TB Survey Overview
- Angela Starks, PhD, Centers for Disease Control and Prevention

M-24 A2- Overview of New DST Guidelines
Moderator - Kenneth C.  Jost, Jr, MT(ASCP), Texas Department of State Health Services

- Edward P. Desmond, PhD, D(ABMM), California Department of Public Health

Drug Susceptibility Testing and TB
Moderator- Kenneth C . Jost, Jr, MT(ASCP), Texas Department of State Health Services

- Jacques Grosset, MD, Center for TB Research

Making the Best Use of New Technologies
Moderator- Michael Iademarco, MD, MPH, Centers for Disease Control and Prevention

Overview of Molecular Methods for the Identifi cation of TB and Mutations Associated with Drug Resistance
- Beverly Metchock, DrPH, Centers for Disease Control and Prevention

Benefits and Limitations of Molecular Testing
- Edward P. Desmond, PhD, D(ABMM), California Department of Public Health

Impact of Treatment on MDR-TB Transmission
- Edward Nardell, MD, Harvard University Medical School

Panel Discussion on Practical Implications
- Barbara Seaworth, MD, Texas Department of State Health Services
- All speakers

Tuesday June 14

Basic Research: Where Are TB Diagnostics Going?
Moderator- Jamie Posey, PhD, Centers for Disease Control and Prevention

Latency- Does it Exist?
- JoAnne Flynn, PhD, University of Pittsburgh School of Medicine

Biomarkers for Treatment, Relapse and Cure
- John Belisle, PhD, Colorado State University

Update: Drug Resistance Mechanisms
- Jamie Posey, PhD, Centers for Disease Control and Prevention

A Time for Change: Mutation Rates and Drug Resistance in Mycobacterium tuberculosis
- Sarah Fortune, MD, Harvard School of Public Health

Reporting Results Faster: An Overview of the State of LIMS
Moderator- Lisa Dettinger, MT(ASCP), Pennsylvania Department of Health

State Updates
- Susie Zanto, CIS(NCA) SM(NRM), Montana Public Health Laboratory
- Lixia Liu, PhD, MP(ASCP), Indiana State Department of Health Laboratories

PHLIP Update
- Jon Lipsky, The St. John Group

Ensuring Quality in the TB Laboratory
Moderator- David Warshauer, PhD, D(ABMM), Wisconsin State Laboratory of Hygiene

Assessment of MPEP Data
- John Ridderhof, DrPH, Centers for Disease Control and Prevention

Making PT Work for You
- David Warshauer, PhD, D(ABMM), Wisconsin State Laboratory of Hygiene

Validation/Verification of Laboratory Developed Tests
- Eileen M. Burd, PhD, Emory University School of Medicine

TB : A Global Disease
Moderator- David Warshauer, PhD, D(ABMM), Wisconsin State Laboratory of Hygiene

International Diagnostic Strategies
- Heather Alexander, PhD, Centers for Disease Control and Prevention

TB Across the Border
- Luis A. Todd, MD, FAAP, Servicios Medicos de la Frontera

GLI Activities – Ventilated Work Station
- Pawan Angra, MS, PhD, Centers for Disease Control and Prevention

Wednesday June 15

Welcome to the National TB Conference and Keynote Address
Moderator- Kimberly Field, RN, PHN, MSN, NTCA, TB Controller, Washington State Department of Health

National TB Controllers Association Welcome
- Kimberly Field, RN, PHN, MSN, NTCA, TB Controller, Washington State Department of Health

Division of TB Elimination Update
- Kenneth G. Castro, MD, Director, Centers for Disease Control and Prevention

NCHHSTP Update
- Hazel Dean, ScD, MPH, Centers for Disease Control and Prevention

Keynote Address – In Pursuit of Tuberculosis Elimination: Then and Now
- Dixie E. Snider, Jr., MD, MPH, Centers for Disease Control and Prevention

New Technologies; New Solutions
Moderator- Angela Starks, PhD, Centers for Disease Control and Prevention

QuantiFERON TB Gold In-Tube Testing in the  Public Health Laboratory
- Daphne Ware, PhD, Mississippi Public Health Laboratory

How We Did It: Implementing QFT Testing for Mass Contact Investigations in Houston
- Barbara Brissette, BSN, RN, Public Health Nurse, City of Houston TB Control

Application of IGRA to a Contact Investigation Involving a Predominant Mexican Population in a Worksite
- Lauri Smithee, PhD, Oklahoma State Department of Health

Update on TO18 and Screening of Health Care Workers
- Randall Reves, MD, MS, Denver Metro TB Control Program

Increasing Utilization of Nucleic Acid Amplification Testing

Expansion of NAAT for TB in Public Health Laboratories: The APHL/CDC TB NAAT Grants
- David Warshauer, PhD, D(ABMM), Wisconsin State Laboratory of Hygiene

APHL Grant Opportunities – A Texas Laboratory Proposal for Enhanced for Direct Testing of Tuberculosis
- Denise Dunbar, Texas Department of Health Services

To view or print the presentations, you must have Adobe Acrobat Reader (version 3.0 or higher) installed on your computer. If you do not have the reader, you can obtain it free from Adobe Corporation.

To save a Acrobat (pdf) file quickly: Right click on the desired version of the presentation and select "Save Target As." This will open a dialog box, allowing you to designate a file name and location.

To view/save an Adobe Acrobat (pdf) file: Click the PDF version of the presentation desired. This will open the presentation in Acrobat or Acrobat Reader within your Internet browser, where it can be viewed by clicking on the pages or using the arrows in the lower right. To save the file click on the "diskette" icon on the Acrobat toolbar, or click the "printer" icon to print directly from your browser. A link to obtain Adobe Acrobat Reader is below, if needed.